TCAF ETF Analysis: T. Rowe Price Capital | NYSE
Large Blend | NYSE, USA | Market Cap: 8.902m USD | 12M Return: 12.5% | US87283Q8675 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 21.8M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 3.3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The T. Rowe Price Capital Appreciation Equity ETF (TCAF) is an actively managed exchange-traded fund that primarily invests in equity securities, allocating at least 80% of its net assets to stocks. While the fund can purchase companies of any size, it typically concentrates on large U.S. issuers, consistent with its Large Blend ETF classification.
The fund may at times hold significant exposure to specific sectors, notably information technology and healthcare-both of which are dominant components of the broad U.S. equity market and major drivers of long-term capital growth. The non-diversified designation means the fund may hold a more concentrated portfolio than diversified peers, allowing for larger positions in individual securities or sectors.
- Large-cap US equities rally lifts TCAF NAV
- IT and healthcare sector concentration amplifies fund returns
- AUM growth expands T. Rowe Price fee revenue
As of October 05, 2026, the stock is trading at USD 42.54 with a total of 535,691 shares traded. Over the past week, the price has changed by -0.42%, over one month by -0.33%, over three months by +2.73% and over the past year by +12.54%.
Current recommended Stop Loss: 41.80 (which is 1.7% or 1.9 ATR below the current price).
T. Rowe Price Capital has no consensus analysts rating.